Drug Side Effects
Search
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT
was reported 67 times
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Histone Deacetylase Inhibitor [EPC]
19
0.0049
1
Mucocutaneous Epithelial Cell Growth Factor [EPC]
1
0.0026
2
CD30-directed Immunoconjugate [EPC]
10
0.0010
3
Cytomegalovirus pUL97 Kinase Inhibitor [EPC]
1
0.0004
4
Antimalarial [EPC]
2
0.0002
5
Antiprotozoal [EPC]
2
0.0002
6
CD52-directed Cytolytic Antibody [EPC]
3
0.0002
7
Topoisomerase Inhibitor [EPC]
11
0.0001
8
Bile Acid [EPC]
3
0.0001
9
Thrombopoietin Receptor Agonist [EPC]
1
0.0001
10
Calcineurin Inhibitor Immunosuppressant [EPC]
8
0.0001
11
Alkylating Drug [EPC]
14
0.0001
12
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
5
0.0001
13
Janus Kinase Inhibitor [EPC]
6
0.0000
14
Leukocyte Growth Factor [EPC]
4
0.0000
15
Corticosteroid [EPC]
21
0.0000
16
Azole Antifungal [EPC]
2
0.0000
17
Platinum-based Drug [EPC]
3
0.0000
18
Nucleoside Metabolic Inhibitor [EPC]
3
0.0000
19
Kinase Inhibitor [EPC]
6
0.0000
20
Estrogen [EPC]
2
0.0000
21
Purine Antimetabolite [EPC]
1
0.0000
22
CD20-directed Cytolytic Antibody [EPC]
3
0.0000
23
Benzodiazepine [EPC]
5
0.0000
24
Xanthine Oxidase Inhibitor [EPC]
1
0.0000
25
Folate Analog Metabolic Inhibitor [EPC]
2
0.0000
26
Insulin Analog [EPC]
2
0.0000
27
Proton Pump Inhibitor [EPC]
2
0.0000
28
Vitamin D [EPC]
1
0.0000
29
Vitamin B12 [EPC]
1
0.0000
30
Vitamin C [EPC]
1
0.0000
31
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000